Trademark: 86156378
Status Date
Monday, August 21, 2017
Filing Date
Thursday, January 2, 2014
Published for Opposition
Tuesday, May 20, 2014
Abandoned Date
Monday, August 21, 2017
5 Pharmaceuticals, namely, drugs for the treatment of cancer, myelodysplastic syndromes, ovarian cancer, pancreatic cancers, solid tumors, and hematological diseases
Mar 14, 2023
Teas Change Of Correspondence Received
Mar 14, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 14, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 21, 2017
Teas Change Of Correspondence Received
Aug 21, 2017
Abandonment Notice Mailed - No Use Statement Filed
Aug 21, 2017
Abandonment - No Use Statement Filed
Jan 17, 2017
Notice Of Approval Of Extension Request E-Mailed
Jan 14, 2017
Sou Extension 5 Granted
Jan 6, 2017
Sou Extension 5 Filed
Jan 6, 2017
Teas Extension Received
Jul 26, 2016
Notice Of Approval Of Extension Request E-Mailed
Jul 24, 2016
Sou Extension 4 Granted
Jul 8, 2016
Sou Extension 4 Filed
Jul 8, 2016
Teas Extension Received
Feb 6, 2016
Notice Of Approval Of Extension Request E-Mailed
Feb 5, 2016
Sou Extension 3 Granted
Jan 4, 2016
Sou Extension 3 Filed
Jan 4, 2016
Teas Extension Received
Jul 27, 2015
Teas Change Of Correspondence Received
Jul 23, 2015
Notice Of Approval Of Extension Request E-Mailed
Jul 22, 2015
Sou Extension 2 Granted
Jun 23, 2015
Sou Extension 2 Filed
Jul 18, 2015
Case Assigned To Intent To Use Paralegal
Jun 23, 2015
Teas Extension Received
Jan 8, 2015
Notice Of Approval Of Extension Request E-Mailed
Jan 6, 2015
Sou Extension 1 Granted
Jan 6, 2015
Sou Extension 1 Filed
Jan 6, 2015
Teas Extension Received
Jul 15, 2014
Noa E-Mailed - Sou Required From Applicant
May 20, 2014
Official Gazette Publication Confirmation E-Mailed
May 20, 2014
Published For Opposition
Apr 30, 2014
Notification Of Notice Of Publication E-Mailed
Apr 10, 2014
Approved For Pub - Principal Register
Apr 3, 2014
Assigned To Examiner
Jan 16, 2014
New Application Office Supplied Data Entered
Jan 6, 2014
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24